2008Shanghai yixueRequires access

Carvedilol antagonizes hypoxia/reoxygenation-induced apoptosis in cultured neonatal rat cardiomyocytes

Yang Dicheng

Open publisher page 0 citations

Abstract

Objective To observe the effects of carvedilol against hypoxia/reoxygenation-induced apopto- sis in cultured neonatal rat cardiomyocytes and explore its possible mechanism.Methods The cardiomyocytes isolated and purified from neonatal SD rats(1 to 3 days old)were cultured for 72 h and divided into the control group,hypoxia/reoxygenation group,and carvedilol-pretreated hypoxia/reoxygenation group.Hypoxia/reoxy- genation model was established by exposing the cardiomyocytes to anoxia for 120 min followed by reoxygenation for 30 min.The protective effect of carvedilol on cardiomyocyte survival after hypoxia/reoxygenation exposure was evaluated,and its effect on Bcl-2 and Bax expression in the cardiomyoctyes was assessed using immunohis- tochemistry.Results The viable cell percentage in the carvedilol-pretreated hypoxia/reoxygenation group was (70.21±2.12)%,significantly higher than that of(58.39±3.22)% in the hypoxia/reoxygenation group.Im- munohistochemistry demonstrated no significant difference in Bcl-2 expression between the carvedilol-pretreated group and the hypoxia/reoxygenation group([12.22±1.62]% vs[20.32±3.62]%,P0.05),but the carve- dilol-pretreated cells showed significantly lowered Bax expression[(32.62±4.22)% vs(40.21±3.22)%,P0.05],resulting in significant difference in the Bcl-2/Bax ratio between the two groups(0.62 vs O.30,P0.05).Conclusion Carvedilol can significantly reduce cardiomyocyte apoptosis in response to hypoxia/reoxy- genation exposure,possibly by inhibiting Bax expression to increase of Bcl-2/Bax ratio in the cardiomyocytes. (Shanghai Med J,2008,31:184-186)

About this research paper

What this paper is about

Objective To observe the effects of carvedilol against hypoxia/reoxygenation-induced apopto- sis in cultured neonatal rat cardiomyocytes and explore its possible mechanism.Methods The cardiomyocytes isolated and purified from neonatal SD rats(1 to 3 days old)were cultured for 72 h and divided into the control group,hypoxia/reoxygenation group,and carvedilol-pretreated hypoxia/reoxygenation group.Hypoxia/reoxy- genation model was established by exposing the cardiomyocytes to anoxia for 120 min followed by reoxygenation for 30 min.The protective effect of carvedilol on cardiomyocyte survival after hypoxia/reoxygenation exposure was evaluated,and its effect on Bcl-2 and Bax expression in the cardiomyoctyes was assessed using immunohis- tochemistry.Results The viable cell percentage in the carvedilol-pretreated hypoxia/reoxygenation group was (70.21±2.12)%,significantly higher than that of(58.39±3.22)% in the hypoxia/reoxygenation group.Im- munohistochemistry demonstrated no significant difference in Bcl-2 expression between the carvedilol-pretreated group and the hypoxia/reoxygenation group([12.22±1.62]% vs[20.32±3.62]%,P0.05),but the carve- dilol-pretreated cells showed significantly lowered Bax expression[(32.62±4.22)% vs(40.21±3.22)%,P0.05],resulting in significant difference in the Bcl-2/Bax ratio between the two groups(0.62 vs O.30,P0.05).Conclusion Carvedilol can significantly reduce cardiomyocyte apoptosis in response to hypoxia/reoxy- genation exposure,possibly by inhibiting Bax expression to increase of Bcl-2/Bax ratio in the cardiomyocytes. (Shanghai Med J,2008,31:184-186)

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of carvedilol against hypoxia/reoxygenation-induced apopto- sis in cultured neonatal rat cardiomyocytes and explore its possible mechanism.Methods The cardiomyocytes isolated and purified from neonatal SD rats(1 to 3 days old)were cultured for 72 h and divided into the control group,hypoxia/reoxygenation group,and carvedilol-pretreated hypoxia/reoxygenation group.Hypoxia/reoxy- genation model was established by exposing the cardiomyocytes to anoxia for 120 min followed by reoxygenation for 30 min.The protective effect of carvedilol on cardiomyocyte survival after hypoxia/reoxygenation exposure was evaluated,and its effect on Bcl-2 and Bax expression in the cardiomyoctyes was assessed using immunohis- tochemistry.Results The viable cell percentage in the carvedilol-pretreated hypoxia/reoxygenation group was (70.21±2.12)%,significantly higher than that of(58.39±3.22)% in the hypoxia/reoxygenation group.Im- munohistochemistry demonstrated no significant difference in Bcl-2 expression between the carvedilol-pretreated group and the hypoxia/reoxygenation group([12.22±1.62]% vs[20.32±3.62]%,P0.05),but the carve- dilol-pretreated cells showed significantly lowered Bax expression[(32.62±4.22)% vs(40.21±3.22)%,P0.05],resulting in significant difference in the Bcl-2/Bax ratio between the two groups(0.62 vs O.30,P0.05).Conclusion Carvedilol can significantly reduce cardiomyocyte apoptosis in response to hypoxia/reoxy- genation exposure,possibly by inhibiting Bax expression to increase of Bcl-2/Bax ratio in the cardiomyocytes. (Shanghai Med J,2008,31:184-186)

Key concepts: Carvedilol, Hypoxia (environmental), Apoptosis, Medicine, Andrology, Pharmacology, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Carvedilol antagonizes hypoxia/reoxygenation-induced apoptosis in cultured neonatal rat cardiomyocytes — Research Paper | ScholarLens